parkinsons glutathione NAD IV Therapy and IV for Parkinson's Disease Glutathione IV Therapy | The

Hospitals and facilities are encouraged to continue to engage in activities to close gaps in care and collect data that is important to their patient care initiatives and reflect the needs of their patient population regardless of whether it is required for the Hospital OQR, REHQR, and ASCQR Programs

When used as a monotherapymeaning its taken on its own, without being combined with other medicationsits currently being tested in a large phase 3 clinical trial program called RENEW

Medically reviewed by Alan Lucks | MD , Alan Lucks MDPC Private Practice - New York on January 10th, 2026

Clinically, reduced glutathione is administered via intravenous injection as a direct and rapid antidote to paracetamol poisoning